- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3(Non-covalent)
- 5 x J77: (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE(Non-covalent)
J77.2: 13 residues within 4Å:- Chain A: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain C: A.24
15 PLIP interactions:14 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:I.108, A:Y.110, A:Y.110, A:F.132, A:Y.157, A:Y.157, A:P.179, A:V.194, A:V.194, A:V.197, A:F.236, A:F.236, A:F.236, C:A.24
- pi-Stacking: A:Y.203
J77.5: 13 residues within 4Å:- Chain E: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain G: A.24
15 PLIP interactions:14 interactions with chain E, 1 interactions with chain G- Hydrophobic interactions: E:I.108, E:Y.110, E:Y.110, E:F.132, E:Y.157, E:Y.157, E:P.179, E:V.194, E:V.194, E:V.197, E:F.236, E:F.236, E:F.236, G:A.24
- pi-Stacking: E:Y.203
J77.8: 13 residues within 4Å:- Chain I: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain K: A.24
15 PLIP interactions:14 interactions with chain I, 1 interactions with chain K- Hydrophobic interactions: I:I.108, I:Y.110, I:Y.110, I:F.132, I:Y.157, I:Y.157, I:P.179, I:V.194, I:V.194, I:V.197, I:F.236, I:F.236, I:F.236, K:A.24
- pi-Stacking: I:Y.203
J77.11: 13 residues within 4Å:- Chain M: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain O: A.24
15 PLIP interactions:1 interactions with chain O, 14 interactions with chain M- Hydrophobic interactions: O:A.24, M:I.108, M:Y.110, M:Y.110, M:F.132, M:Y.157, M:Y.157, M:P.179, M:V.194, M:V.194, M:V.197, M:F.236, M:F.236, M:F.236
- pi-Stacking: M:Y.203
J77.14: 13 residues within 4Å:- Chain Q: I.108, Y.110, F.132, Y.157, P.179, I.192, V.194, V.197, Y.203, S.204, F.236, L.239
- Chain S: A.24
15 PLIP interactions:14 interactions with chain Q, 1 interactions with chain S- Hydrophobic interactions: Q:I.108, Q:Y.110, Q:Y.110, Q:F.132, Q:Y.157, Q:Y.157, Q:P.179, Q:V.194, Q:V.194, Q:V.197, Q:F.236, Q:F.236, Q:F.236, S:A.24
- pi-Stacking: Q:Y.203
- 5 x MYR: MYRISTIC ACID(Covalent)
MYR.3: 10 residues within 4Å:- Chain D: G.1, A.2, Y.31
- Chain H: V.4, T.27, I.29, Y.31
- Chain O: L.2
- Ligands: MYR.6, MYR.15
2 PLIP interactions:1 interactions with chain H, 1 interactions with chain O- Hydrogen bonds: H:T.27
- Hydrophobic interactions: O:L.2
MYR.6: 10 residues within 4Å:- Chain H: G.1, A.2, Y.31
- Chain L: V.4, T.27, I.29, Y.31
- Chain S: L.2
- Ligands: MYR.3, MYR.9
1 PLIP interactions:1 interactions with chain S- Hydrophobic interactions: S:L.2
MYR.9: 10 residues within 4Å:- Chain C: L.2
- Chain L: G.1, A.2, Y.31
- Chain P: V.4, T.27, I.29, Y.31
- Ligands: MYR.6, MYR.12
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.2
MYR.12: 10 residues within 4Å:- Chain G: L.2
- Chain P: G.1, A.2, Y.31
- Chain T: V.4, T.27, I.29, Y.31
- Ligands: MYR.9, MYR.15
2 PLIP interactions:1 interactions with chain T, 1 interactions with chain G- Hydrogen bonds: T:T.27
- Hydrophobic interactions: G:L.2
MYR.15: 10 residues within 4Å:- Chain D: V.4, T.27, I.29, Y.31
- Chain K: L.2
- Chain T: G.1, A.2, Y.31
- Ligands: MYR.3, MYR.12
2 PLIP interactions:1 interactions with chain K, 1 interactions with chain D- Hydrophobic interactions: K:L.2
- Hydrogen bonds: D:T.27
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)
- Release Date
- 1996-07-11
- Peptides
- POLIOVIRUS TYPE 3: AEIMQ
POLIOVIRUS TYPE 3: BFJNR
POLIOVIRUS TYPE 3: CGKOS
POLIOVIRUS TYPE 3: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1B
2F
2J
2N
2R
2C
3G
3K
3O
3S
3D
4H
4L
4P
4T
4
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.80 Å
- Oligo State
- hetero-5-5-5-5-mer
- Ligands
- 5 x ILE- SER- GLU- VAL: POLIOVIRUS TYPE 3(Non-covalent)
- 5 x J77: (METHYLPYRIDAZINE PIPERIDINE ETHYLOXYPHENYL)ETHYLACETATE(Non-covalent)
- 5 x MYR: MYRISTIC ACID(Covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Grant, R.A. et al., Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr.Biol. (1994)
- Release Date
- 1996-07-11
- Peptides
- POLIOVIRUS TYPE 3: AEIMQ
POLIOVIRUS TYPE 3: BFJNR
POLIOVIRUS TYPE 3: CGKOS
POLIOVIRUS TYPE 3: DHLPT - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
1E
1I
1M
1Q
1B
2F
2J
2N
2R
2C
3G
3K
3O
3S
3D
4H
4L
4P
4T
4